The Medicaid redetermination process is off to a poor start, according to Adrianna McIntyre, PhD, an assistant professor of health policy and politics at Boston-based Harvard T.H. Chan School of Public Health.
Payer
Five of the 10 drugs with the highest Medicare Part D spending are diabetes treatments, including Ozempic, according to an analysis from KFF.
Johns Hopkins HealthCare, the insurance arm of Baltimore-based Johns Hopkins Medicine, is rebranding as Johns Hopkins Health Plans.
The Cigna Group named a new leader for its Medicare business and settled several legal actions in recent weeks.
From specialty Medicare Advantage plans to continued investment in care delivery services, these are six payers entering new markets, as reported by Becker's since April 1:
The Minnesota Department of Commerce has fined Medica $300,000 and imposed a two-year monitoring period for what it says are violations of mental health parity laws.
Price transparency data is available, but several changes are needed to actually bring about lower healthcare costs, researchers at Washington, D.C.-based Georgetown University's Center for Health Insurance Reforms wrote.
Two nonprofit Blue Cross Blue Shield companies will reorganize this year, hoping to stay competitive with for-profit rivals like UnitedHealth Group and Aetna.
17 payers have been recognized for their initiatives around disability inclusion and equality for their employees in the 2023 Disability Equality Index, a national benchmarking survey created by Disability:IN and the American Association of People with Disabilities.
The North Carolina Department of Health and Human Services is again delaying the implementation of its Medicaid managed care behavioral health and intellectual/developmental disabilities tailored plans, this time to an undetermined date.
